SB 3545 – Illinois
Introduced: 2020 Status: Inactive / Dead
INS/ANTI-SEIZURE DRUG COVERAGE. Amends the Illinois Insurance Code. Provides that an individual or group policy of accident and health insurance amended, delivered, issued, or renewed after the effective date of the amendatory Act shall provide …
SB 3733 – Illinois
Introduced: 2020 Status: Inactive / Dead
INS-GENERIC PRESCRIPTION DRUGS. Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for …
SB 39 – Alabama
Introduced: 2019 Status: Inactive / Dead
Relating to pharmacists and the requirements for prescriptions and the dispensing of prescriptions; to amend Section 34-23-8 of the Code of Alabama 1975, to specify that, unless a physician or other practitioner indicates otherwise, a …
SB 4 – Oklahoma
Introduced: 2021 Status: Enacted
SB 4 authorizes a pharmacist to substitute an interchangeable biological product for a prescribed biological product under certain conditions. The measure specifies that the substituted product be determined by the FDA to be interchangeable. The …
SB 45 – Kentucky
Introduced: 2021 Status: Enacted
AN ACT relating to prescription drugs. Amend KRS 304.17A-164 to redefine “cost sharing” and define “generic alternative,” “health plan,” “insured,” and “person”; prohibit an insurer or pharmacy benefit manager from excluding any cost-sharing amount paid …
SB 48 – Connecticut
Introduced: 2019 Status: Inactive / Dead
To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
SB 5203 – Washington
Introduced: 2021 Status: Enacted
HCA may enter into partnerships with another state, a group of states, a state agency, a nonprofit organization, or any other entity to produce, distribute, or purchase generic prescription drugs and purchase and distribute insulin. …
SB 5601 (see companion bill HB 1562) – Washington
Introduced: 2019 Status: Enacted
CONCERNING HEALTH CARE BENEFIT MANAGEMENT. A health care benefit manager doing business as a pharmacy may not place a drug on a list unless there are at least two therapeutically equivalent multiple source drugs, or …
SB 5699 – Washington
Introduced: 2017 Status: Inactive / Dead
PHARMACY APPEALS OF PAYMENTS MADE BY PHARMACY BENEFIT MANAGERS: The PBM must uphold the appeal of a pharmacy if the pharmacy can demonstrate that it is unable to purchase a therapeutically equivalent interchangeable product from …
SB 575 (see companion bill AB 679) – Wisconsin
Introduced: 2017 Status: Enacted
A pharmacist shall dispense every prescription using either the biological product prescribed or an interchangeable biological product, if the interchangeable biological product is lower in price to the consumer than the biological product prescribed, and …
SB 5995 (see companion bill HB 2556) – Washington
Introduced: 2018 Status: Inactive / Dead
GENERIC PRESCRIPTION DRUG PRICES: Protects consumers and purchasers from excessive increases in generic prescription drug prices, requires a drug manufacture to use a price increase notification form when there is an increase in the wholesale acquisition …
SB 621 – California
Introduced: 2023 Status: Enacted
Health care coverage: biosimilar drugs. This bill would specify that a plan, insurer, or utilization review organization is also not prohibited from requiring an enrollee or insured to try a biosimilar before providing coverage for …
SB 641 – Connecticut
Introduced: 2021 Status: Inactive / Dead
AN ACT REQUIRING MANUFACTURERS OF BRAND-NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS. To promote competition in the prescription drug market by allowing developers of generic drugs and …
SB 649 – Connecticut
Introduced: 2021 Status: Inactive / Dead
AN ACT CONCERNING THE AVAILABILITY OF GENERIC PHARMACEUTICALS. To preserve patient access to affordable prescription drugs.
SB 75 – South Dakota
Introduced: 2018 Status: Enacted Year Enacted: 2018
This bill would permit pharmacist dispensing prescription drug order for a biological product prescribed by its brand or proper name to select an interchangeable biological product of the prescribed product. Would prohibit pharmacist from dispensing …
SB 764 – Oregon
Introduced: 2021 Status: Inactive / Dead
Provides that court must presume that resolution agreement that ends dispute over alleged infringement of patent or violation of other protection for protected drug has anticompetitive effects if alleged infringer receives item of value as …